4//SEC Filing
Gurrola Sandra M 4
Accession 0001140361-23-031258
CIK 0000748592other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:30 PM ET
Size
8.2 KB
Accession
0001140361-23-031258
Insider Transaction Report
Form 4
Gurrola Sandra M
VP of Finance
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-06-21−438→ 874 total→ Common Stock (438 underlying) - Exercise/Conversion
Common Stock
2023-06-21+438→ 1,107 total - Tax Payment
Common Stock
2023-06-21$2.48/sh−179$444→ 928 total
Footnotes (2)
- [F1]Each restricted stock unit converts into one share of common stock.
- [F2]On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
Documents
Issuer
Eterna Therapeutics Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001618457
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 8:30 PM ET
- Size
- 8.2 KB